RET is a transmembrane protein tyrosine kinase characterized by proto-oncogenic properties, and it has been identified as a potential promoter of the invasive capabilities of prostate cancer through the activation of p70S6 kinase [97]. This evidence concerns the gene RET and prostate carcinoma.